Sarepta 5051-102: An Open-Label Extension Study for Patients with Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051

Project: Research project

Project Details

StatusActive
Effective start/end date3/26/198/31/50

Funding

  • Sarepta Therapeutics, Inc.
  • Sarepta Therapeutics, Inc.